Substituted-Vinyl Hydroxytriarylethylenes, 1-[4-[2-(Diethylamino)ethoxy]phenyl]-1-(4-hydroxyphenyl)-2-phenylethylenes: Synthesis and Effects on MCF 7 Breast Cancer Cell Proliferation

Journal of Medicinal Chemistry

Volumn 29, Issue 12, 1986, Pages 2511-2519

  Ruenitz, Peter C ^a   Bagley, Jerome R ^a   Watts, Colin K ^a   Hall, Rosemary E ^a   Sutherland, Robert L ^a  

^a Division of Medicinal Chemistry and Pharmocognosy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [4 (2 DIETHYLAMINOETHOXY)PHENYL] 1 (4 HYDROXYPHENYL) 1 BUTENE; 1 [4 (2 DIETHYLAMINOETHOXY)PHENYL] 1 (4 HYDROXYPHENYL) 2 NITROETHYLENE; 1 [4 (2 DIETHYLAMINOETHOXY)PHENYL] 1 (4 HYDROXYPHENYL)ETHYLENE; 2 BROMO 1 [4 (2 DIETHYLAMINOETHOXY)PHENYL] 1 (4 HYDROXYPHENYL)ETHYLENE; 2 CYANO 1 [4 (2 DIETHYLAMINOETHOXY)PHENYL] 1 (4 HYDROXYPHENYL)ETHYLENE; 4 HYDROXYCLOMIFENE; ANTIESTROGEN; ANTINEOPLASTIC AGENT; ESTRADIOL H 3; NEW DRUG; RADIOISOTOPE; TAMOXIFEN DERIVATIVE; TAMOXIFEN H 3; UNCLASSIFIED DRUG;

ARTICLE; BREAST; BREAST CANCER; CANCER CHEMOTHERAPY; CELL CYCLE; DOSE RESPONSE; DRUG ANALYSIS; DRUG ANTAGONISM; DRUG COMPARISON; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SCREENING; DRUG SENSITIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTOXICATION; PHARMACOKINETICS; PRIORITY JOURNAL; THERAPY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; FEMALE; HUMANS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0023017928     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00162a014     Document Type: Article

References (38)

1. Sutherland, R.L.; Murphy, L.C. Mol. Cell. Endocrinol. 1982, 25, 5–23.
2. Jordan, V.C. Pharmacol. Rev. 1984, 36, 245–276.
3. Sutherland, R.L.; Murphy, L.C.; Hall, R.E.; Reddel, R.R.; Watts, C.K.W.; Taylor, I.W. In Progress in Cancer Research and Therapy. Bresciani, F., Et al., Eds.; Raven: New York, 1984; Vol. 31, pp 193–212.
4. Coezy, E.; Borgna, J.-L.; Rochefort, H. Cancer Res. 1982, 42, 317–323.
5. Roos, W.; Oeze, L.; Loser, R.; Eppenberger, U. JNCI J. Natl. Cancer Inst. 1983, 71, 55–59.
6. Reddel, R.R.; Murphy, L.C.; Sutherland, R.L. Cancer Res. 1983, 43, 4618–4624.
7. Marth, C.; Daxenbichler, G.; Buehring, G.C.; Hofstadter, F.; Dapunt, O. Biochem. Pharmacol. 1984, 33, 3951–3956.
8. Murphy, L.C.; Sutherland, R.L. J. Clin. Endocrinol. Me-tab. 1983, 57, 373–379.
9. Murphy, L.C.; Sutherland, R.L. Endocrinology (Baltimore) 1985, 116, 1071–1078.
10. Jordan, V.C.; Collins, M.M.; Rowsby, L.; Prestwich, G. J. Endocrinol. 1977, 75, 305–316.
11. Hayes, J.R.; Rorke, E.A.; Robertson, D.W.; Katzenellenbogen, B.S.; Katzenellenbogen, J.A. Endocrinology (Baltimore) 1981, 108, 164–172.
12. Ruenitz, P.C.; Bagley, J.R.; Mokler, C.M. Biochem. Pharmacol. 1983, 32, 2941–2947.
13. Soule, H.D.; Vazquez, J.; Long, A.; Albert, S.; Brennan, M. J. Natl. Cancer Inst. (U.S.) 1973, 57, 1409–1416.
14. Sutherland, R.L.; Hall, R.E.; Taylor, I.W. Cancer Res. 1983, 43, 3998–4006.
15. Robertson, D.W.; Katzenellenbogen, J.A.; Long, D.J.; Rorke, E.A.; Katzenellenbogen, B.S. J. Steroid Biochem. 1982, 16, 1–13.
16. Harper, M.J.K.; Richardson, D.N.; Walpole, A.L. British Patent 106, 1967.
17. Collins, D.J.; Hobbs, J.J.; Emmens, C.W. J. Med. Chem. 1971, 14, 952–957.
18. Buu-Hoi, N.P.; Lecocq, J. J. Chem. Soc. 1947, 641–644.
19. Pickard, P.L.; Tolbert, T.L. J. Org. Chem. 1961, 26, 4886–4888.
20. Corey, E.J.; Gras, J.-L.; Ulrich, P. Tetrahedron Lett. 1976, 809–812.
21. Quick, J.; Ramachandra, R. Synth. Commun. 1978, 8, 511–514.
22. Bedford, G.R.; Richardson, D.N. Nature (London) 1966, 212, 733–734.
23. Kilbourn, B.T.; Mais, R.H.B.; Owston, P.G. Chem. Commun. 1968, 291.
24. Kilbourn, B.T.; Owston, P.G. J. Chem. Soc. B 1970, 1–5.
25. Ruenitz, P.C.; Bagley, J.R.; Mokler, C.M. J. Med. Chem. 1982, 25, 1056–1060.
26. Murphy, L.C.; Sutherland, R.L. Biochem. Biophys. Res. Commun. 1981, 100, 1353–1360.
27. Watts, C.K.W.; Murphy, L.C.; Sutherland, R.L. J. Biol. Chem. 1983, 259, 4223–4229.
28. Watts, C.K.W.; Sutherland, R.L. Biochem. J. 1986, 236, 903–911.
29. Lam, H.-Y.P. Biochem. Biophys. Res. Commun. 1984, 118, 27–32.
30. O';Brian, C.A.; Liskamp, R.M.; Solomon, D.H.; Weinstein, I.B. Cancer. Res, 1985, 45, 2462–2465.
31. Sutherland, R.L.; Green, M.D.; Hall, R.E.; Reddel, R.R.; Taylor, I.W. Eur. J. Cancer Clin. Oncol. 1983, 19, 615–621.
32. Sutherland, R.L.; Hall, R.E.; Taylor, I.W. Cancer Res. 1983, 43, 3998–4006.
33. Reddel, R.R.; Murphy, L.C.; Hall, R.E.; Sutherland, R.L. Cancer Res. 1985, 45, 1525–1531.
34. Wei, J.-W.; Hickie, R.A.; Klaassen, D. J. Cancer Chemother. Pharmacol. 1983, 11, 86–90.
35. Chafouleas, J.G.; Bolton, W.E.; Hidaka, H.; Boyd, A.E.; Means, A.R. Cell (Cambridge, Mass.) 1982, 28, 41–50.
36. Craze, G.-A.; Kirby, A.J. J. Chem. Soc., Perkin Trans. 2, 1978, 354–356.
37. Lednicer, D.U.S. Patent 3, 274, 1966.
38. Chem. Abstr. 1967, 66, 2416.